CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL
Clinical trials for CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL explained in plain language.
Never miss a new study
Get alerted when new CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL trials appear
Sign up with your email to follow new studies for CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart attack survivors with gene variant may benefit from colchicine
Disease control Recruiting nowThis pilot study tests whether the drug colchicine can reduce artery plaque in 120 heart attack survivors who have a specific genetic change (TET2-CHIP). Participants take colchicine or standard care for 12 months. The goal is to see if this genetic marker can guide personalized …
Matched conditions: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL
Phase: PHASE4 • Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Scientists launch 20-Year MDS watch to unlock disease secrets
Knowledge-focused Recruiting nowThis study follows people with myelodysplastic syndromes (MDS) for up to 20 years to understand how the disease changes over time. Researchers will collect blood, bone marrow, and other samples from 1,100 participants, including healthy donors. The goal is to learn more about MDS…
Matched conditions: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
10-Year study tracks hidden DNA changes that raise risk of cancer and heart disease
Knowledge-focused Recruiting nowThis study follows 306 adults with certain DNA changes in their blood cells (called CHIP or CCUS) to see how these changes affect health over time. Researchers want to learn if these changes increase the risk of blood cancers or heart problems. Participants will have yearly check…
Matched conditions: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can we predict blood cancer in ovarian cancer survivors?
Knowledge-focused Recruiting nowThis study follows 2,000 people who have had ovarian or other solid cancers to learn why some later develop blood cancers like leukemia. Researchers will look at genetic changes in blood cells and treatment history to identify risk factors. No new treatments are being tested—the …
Matched conditions: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Firefighter blood study seeks to uncover cancer clues
Knowledge-focused Recruiting nowThis study looks at whether firefighters' exposure to hazardous chemicals leads to pre-cancerous changes in their blood. Researchers will collect blood samples from 300 firefighters aged 40-49 with at least 5 years on the job. The goal is to find early markers that might predict …
Matched conditions: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Scientists peek inside bone marrow to decode aging blood mutations
Knowledge-focused Recruiting nowThis study collects bone marrow from 24 adults aged 65+ having hip surgery to understand how common aging-related blood cell mutations (called CHIP) change cell metabolism. Researchers will compare gene activity in mutated versus normal stem cells. The goal is to learn more about…
Matched conditions: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL
Sponsor: Imelda Hospital, Bonheiden • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
New study uses DNA tests to catch blood cancers before they start
Knowledge-focused Recruiting nowThis study is looking at 2,000 people who have early warning signs of blood cancers or bone marrow failure. Researchers use a special genetic test (next generation sequencing) to find changes in cancer-related genes. The goal is to better understand who is at risk and to catch th…
Matched conditions: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC